Columbia Financ SEC Filings

Columbia Financial, Inc. (CLBK) director Daria Stacy-Walls reported purchases and awards that increased her stake. On 10/03/2025 she was credited with 620.6628 phantom stock units purchased at $14.89 through the Bank's rabbi trust under the Stock Based Deferral Plan; those units will settle in shares when distributed. The filing shows 8,048 shares acquired (direct) and 3,207 shares held indirectly from a stock award that vests on 03/11/2026. After these transactions her total beneficial ownership is reported as 26,297.3924 shares (indirect). The stock award is governed by the 2019 Equity Incentive Plan and the deferral units are non-qualified and non-discretionary.

Columbia Financial, Inc. (CLBK) director Lucy Sorrentini reported stock-based award activity on 10/03/2025. The filing shows a purchase of 160.4822 phantom stock units at a price of $14.89 under the Columbia Bank Stock Based Deferral Plan; those units are held indirectly in a rabbi trust and will be settled in shares upon distribution. After the reported transactions, the reporting person beneficially owns 7,373.456 shares (indirect), plus disclosure of 11,664 shares disposed and 3,207 shares held indirectly from a stock award. Separately, stock awards granted under the 2019 Equity Incentive Plan vest in one year on 03/11/2026. The report is signed under power of attorney and filed on 10/07/2025.

Insider stock changes for Columbia Financial, Inc. (CLBK): An executive, William Justin Jennings (EVP, Operations Officer and Director), reported a non-derivative acquisition on 10/03/2025 of 50.3694 stock units purchased at $14.89 under a rabbi trust tied to the company’s Stock Based Deferral Plan; those units will be settled in shares on distribution. The filing also discloses existing indirect beneficial ownership across several plans: 11,754 shares (unspecified plan), 3,116 via the ESOP, 608 via the SERP, and awards of 7,795 and 7,533 under two stock award schedules. Derivative holdings include fully vested/options exercisable for 41,475, 5,715, and 13,051 common shares with exercise prices of $21.79, $16.49, and $16.23, respectively.

Columbia Financial, Inc. director and President & CEO reported insider activity on 10/03/2025. The filing shows an acquisition (code A) of 120.0222 common stock units at a price of $14.89, recorded as phantom stock purchased under a non-qualified stock-based deferral plan that will settle in shares on distribution. The report lists a beneficial ownership total of 65,790.9122 shares following the transaction (held indirectly), a disposition of 233,808 common shares, and multiple indirect holdings across retirement and deferral plans including a 401(k), ESOP, SERP, SIM and spouse-held shares. The filing also shows sizeable stock option positions exercisable through 2035 with strike prices ranging from $15.60 to $16.49, and notes various time- and performance-based vesting schedules for recent stock awards.

Insider purchase and holdings summary: An officer of Columbia Financial, Inc. (CLBK), Allyson Katz Schlesinger, reported an open-market purchase on 10/03/2025 of 22.4728 shares at $14.89. Following the transaction, she beneficially owns 13,412.6474 shares indirectly through a stock-based deferral plan and additional indirect holdings across an ESOP, SERP, SIM and multiple stock awards and options. The filing also discloses 198,785 underlying common shares available via stock options and vested awards exercisable through 2035.

The report clarifies vesting schedules for several equity awards and notes settlement mechanics for phantom stock in a rabbi trust. This is a routine Section 16 report documenting compensation-related holdings and a small purchase by an executive.

Columbia Financial, Inc. (CLBK) director Randall Elizabeth E. reported a non‑derivative acquisition on 10/03/2025. The filing shows 165.6595 phantom stock units purchased at $14.89 under a rabbi trust linked to the Columbia Bank Stock Based Deferral Plan; those units will be settled in shares when distributed. After the transactions the reporting person holds equity across accounts: 9,676.2106 shares indirectly via the deferral plan, 44,447 shares indirectly in an IRA, 6,704 shares in an IRA, and 3,207 shares in a Roth IRA. The filing also discloses 62,474 vested stock options (strike $15.60, exercisable through 07/23/2029) and a stock award that vests on 03/11/2026.

Matthew James Smith, SEVP & COO of Columbia Financial, Inc. (CLBK), reported a disposal of 15,443 common shares on 10/05/2025 via a Form 4 filing. The transaction is recorded as a disposition at a price of $0, and the filing shows 0 shares beneficially owned following the transaction on an indirect basis. The Form 4 was signed by a power of attorney on 10/07/2025.

Columbia Financial, Inc. (CLBK) Form 4 summary: The company's SEVP & Chief Risk Officer reported a transaction dated 10/03/2025 showing an acquisition of 42.8785 stock units at a price of $14.89 under the Stock Based Deferral Plan. The filing lists multiple existing holdings held directly or indirectly, including 60,769 shares reported as disposed, several indirect holdings through retirement and award plans, and large outstanding stock option positions.

The filing also shows fully vested and exercisable options representing 188,235 underlying common shares from a $15.60 strike option series, plus additional option tranches totaling 41,190 shares with strikes between $15.94 and $16.49. The report was signed by a power of attorney on behalf of the reporting person.

Noel R. Holland, a director of Columbia Financial, Inc. (CLBK), reported changes in beneficial ownership dated 10/03/2025. The filing shows an acquisition of 11.1873 stock units purchased through a rabbi trust under the stock-based deferral plan at a price of $14.89. The report also shows a disposition of 33,519 common shares and continued indirect holdings of 46,280 shares in a SEP-IRA plus 3,207 shares held via a stock award that vests on 03/11/2026. The reporting person holds 83,294 exercisable stock options with an exercise price of $15.60 expiring on 07/23/2029.

The filing includes explanations that the acquired units are phantom stock under the Columbia Bank Stock Based Deferral Plan and will be settled in shares on distribution; the stock awards vest in one year and the noted options are fully vested and exercisable.